|
業務類別
|
Biotechnology |
|
業務概覽
|
Dyadic International Inc is a worldwide biotechnology platform company. It has developed a gene expression platform for producing commercial quantities of industrial enzymes and other proteins and has licensed this technology to third parties, such as Abengoa Bioenergy, BASF, Codexis and others, for use in industrial (non-pharmaceutical) applications. This technology is based on the Thermothelomyces heterothallica fungus, which the company named C1. |
| 公司地址
| 1044 North U.S. Highway One, Suite 201, Jupiter, FL, USA, 33477 |
| 電話號碼
| +1 561 743-8333 |
| 傳真號碼
| +1 561 743-8343 |
| 公司網頁
| https://www.dyadic.com |
| 員工數量
| 6 |
| Dr. Ronen Tchelet, PhD |
Vice President of Research and Business Development |
-- |
29/04/2025 |
| Mr. Joseph Hazelton |
President and Chief Operating Officer |
美元 272.99K |
02/06/2025 |
| Mr. Mark A. Emalfarb |
Director and Chief Executive Officer |
美元 586.00K |
02/06/2025 |
| Ms. Ping W. Rawson, M.B.A. |
Chief Financial Officer and Principal Accounting Officer |
美元 266.44K |
29/04/2025 |
|
|
| Mr. Patrick K. Lucy |
Chairman of the Board |
29/04/2025 |
| Mr. Jack L. Kaye |
Independent Director |
29/04/2025 |
| Mr. Mark A. Emalfarb |
Director and Chief Executive Officer |
02/06/2025 |
| Mr. Seth J. Herbst, M.D. |
Independent Director |
29/04/2025 |
|
|
|
|
